nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2D6—Parkinson's disease	0.857	1	CbGaD
Perhexiline—CPT1A—cardiovascular system—Parkinson's disease	0.00364	0.0881	CbGeAlD
Perhexiline—CPT2—cardiovascular system—Parkinson's disease	0.00345	0.0836	CbGeAlD
Perhexiline—CPT2—medulla oblongata—Parkinson's disease	0.00295	0.0715	CbGeAlD
Perhexiline—CPT2—midbrain—Parkinson's disease	0.0027	0.0653	CbGeAlD
Perhexiline—CPT2—spinal cord—Parkinson's disease	0.00263	0.0637	CbGeAlD
Perhexiline—CPT1A—head—Parkinson's disease	0.00246	0.0597	CbGeAlD
Perhexiline—CPT2—head—Parkinson's disease	0.00234	0.0566	CbGeAlD
Perhexiline—CPT2—nervous system—Parkinson's disease	0.00222	0.0537	CbGeAlD
Perhexiline—CPT1A—cerebellum—Parkinson's disease	0.0022	0.0532	CbGeAlD
Perhexiline—CPT2—central nervous system—Parkinson's disease	0.00213	0.0517	CbGeAlD
Perhexiline—CPT2—cerebellum—Parkinson's disease	0.00209	0.0505	CbGeAlD
Perhexiline—CPT1A—brain—Parkinson's disease	0.00179	0.0432	CbGeAlD
Perhexiline—CPT2—brain—Parkinson's disease	0.00169	0.041	CbGeAlD
Perhexiline—CYP2D6—hindbrain—Parkinson's disease	0.00143	0.0346	CbGeAlD
Perhexiline—CYP2B6—cardiovascular system—Parkinson's disease	0.000898	0.0218	CbGeAlD
Perhexiline—CYP2D6—brainstem—Parkinson's disease	0.000818	0.0198	CbGeAlD
Perhexiline—CYP2D6—forebrain—Parkinson's disease	0.00079	0.0191	CbGeAlD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000787	0.00776	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000766	0.00755	CbGpPWpGaD
Perhexiline—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000761	0.00751	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000745	0.00735	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TH—Parkinson's disease	0.000741	0.0073	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000739	0.00729	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—HTR7—Parkinson's disease	0.000728	0.00718	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—DRD2—Parkinson's disease	0.000728	0.00718	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000709	0.00699	CbGpPWpGaD
Perhexiline—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000677	0.00667	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ND3—Parkinson's disease	0.000667	0.00658	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MCCC1—Parkinson's disease	0.000667	0.00658	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000656	0.00647	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—OMD—Parkinson's disease	0.000627	0.00619	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TALDO1—Parkinson's disease	0.000627	0.00619	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000624	0.00616	CbGpPWpGaD
Perhexiline—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000619	0.0061	CbGpPWpGaD
Perhexiline—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000611	0.00602	CbGpPWpGaD
Perhexiline—CYP2B6—head—Parkinson's disease	0.000608	0.0147	CbGeAlD
Perhexiline—CPT2—Metabolism—NDUFB11—Parkinson's disease	0.000595	0.00587	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000582	0.00574	CbGpPWpGaD
Perhexiline—CYP2B6—nervous system—Parkinson's disease	0.000577	0.014	CbGeAlD
Perhexiline—CPT2—Metabolism—GCH1—Parkinson's disease	0.000567	0.0056	CbGpPWpGaD
Perhexiline—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000566	0.00558	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000564	0.00556	CbGpPWpGaD
Perhexiline—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000557	0.00549	CbGpPWpGaD
Perhexiline—CYP2B6—central nervous system—Parkinson's disease	0.000555	0.0135	CbGeAlD
Perhexiline—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000544	0.00537	CbGpPWpGaD
Perhexiline—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000518	0.0051	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000517	0.0051	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000512	0.00505	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00051	0.00503	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GBA—Parkinson's disease	0.000506	0.00499	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—FBP1—Parkinson's disease	0.000506	0.00499	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—DBH—Parkinson's disease	0.000506	0.00499	CbGpPWpGaD
Perhexiline—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000498	0.00491	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000491	0.00484	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000484	0.00477	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000473	0.00466	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000467	0.0046	CbGpPWpGaD
Perhexiline—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000467	0.0046	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000465	0.00458	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ND3—Parkinson's disease	0.000463	0.00456	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MCCC1—Parkinson's disease	0.000463	0.00456	CbGpPWpGaD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00046	0.00454	CbGpPWpGaD
Perhexiline—CYP2D6—head—Parkinson's disease	0.000452	0.011	CbGeAlD
Perhexiline—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000451	0.00445	CbGpPWpGaD
Perhexiline—CYP2B6—brain—Parkinson's disease	0.000441	0.0107	CbGeAlD
Perhexiline—CYP3A4—nervous system—Parkinson's disease	0.000436	0.0106	CbGeAlD
Perhexiline—CPT1A—Metabolism—TALDO1—Parkinson's disease	0.000435	0.00429	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—OMD—Parkinson's disease	0.000435	0.00429	CbGpPWpGaD
Perhexiline—CYP2D6—nervous system—Parkinson's disease	0.000429	0.0104	CbGeAlD
Perhexiline—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000427	0.00421	CbGpPWpGaD
Perhexiline—CYP3A4—central nervous system—Parkinson's disease	0.000419	0.0102	CbGeAlD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000419	0.00413	CbGpPWpGaD
Perhexiline—CYP2D6—central nervous system—Parkinson's disease	0.000413	0.01	CbGeAlD
Perhexiline—CPT1A—Metabolism—NDUFB11—Parkinson's disease	0.000412	0.00407	CbGpPWpGaD
Perhexiline—CYP2D6—cerebellum—Parkinson's disease	0.000403	0.00977	CbGeAlD
Perhexiline—CPT1A—Metabolism—GCH1—Parkinson's disease	0.000393	0.00388	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000392	0.00387	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000391	0.00386	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000383	0.00378	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—DDC—Parkinson's disease	0.000371	0.00366	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00037	0.00365	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000369	0.00364	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000367	0.00362	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000355	0.0035	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTA4—Parkinson's disease	0.000351	0.00346	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GBA—Parkinson's disease	0.000351	0.00346	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—FBP1—Parkinson's disease	0.000351	0.00346	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—DBH—Parkinson's disease	0.000351	0.00346	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000346	0.00341	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000339	0.00334	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTA4—Parkinson's disease	0.000336	0.00332	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000332	0.00327	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000329	0.00324	CbGpPWpGaD
Perhexiline—CYP2D6—brain—Parkinson's disease	0.000328	0.00794	CbGeAlD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000324	0.0032	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PLA2G6—Parkinson's disease	0.000316	0.00311	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000316	0.00311	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MAOB—Parkinson's disease	0.000312	0.00308	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—MAOB—Parkinson's disease	0.0003	0.00296	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000297	0.00293	CbGpPWpGaD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000277	0.00274	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000277	0.00273	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000268	0.00265	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000267	0.00263	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000266	0.00262	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000264	0.00261	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—DDC—Parkinson's disease	0.000257	0.00254	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000256	0.00253	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTA4—Parkinson's disease	0.000243	0.0024	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00024	0.00237	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000235	0.00232	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000234	0.0023	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP2D6—Parkinson's disease	0.000232	0.00229	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000232	0.00229	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00023	0.00227	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CTGF—Parkinson's disease	0.000228	0.00225	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP2D6—Parkinson's disease	0.000223	0.0022	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00022	0.00217	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000219	0.00216	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PLA2G6—Parkinson's disease	0.000219	0.00216	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000217	0.00214	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MAOB—Parkinson's disease	0.000217	0.00214	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000215	0.00212	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP2E1—Parkinson's disease	0.000212	0.00209	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000212	0.00209	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NQO1—Parkinson's disease	0.00021	0.00207	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000208	0.00205	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TH—Parkinson's disease	0.000207	0.00204	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000206	0.00203	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP2E1—Parkinson's disease	0.000204	0.00201	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000201	0.00198	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYCS—Parkinson's disease	0.000199	0.00196	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000191	0.00188	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—IL6—Parkinson's disease	0.000177	0.00174	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—COMT—Parkinson's disease	0.000176	0.00174	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTP1—Parkinson's disease	0.000175	0.00173	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MAOA—Parkinson's disease	0.000175	0.00172	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000174	0.00172	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—HMOX1—Parkinson's disease	0.000173	0.0017	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—COMT—Parkinson's disease	0.000169	0.00166	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTP1—Parkinson's disease	0.000168	0.00166	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—MAOA—Parkinson's disease	0.000168	0.00165	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—COMT—Parkinson's disease	0.000166	0.00164	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ABCB1—Parkinson's disease	0.000166	0.00163	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000166	0.00163	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTM1—Parkinson's disease	0.000161	0.00159	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP2D6—Parkinson's disease	0.000161	0.00159	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CTGF—Parkinson's disease	0.000158	0.00156	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTM1—Parkinson's disease	0.000154	0.00152	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GPX1—Parkinson's disease	0.000154	0.00152	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000153	0.00151	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000152	0.0015	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000151	0.00149	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP2E1—Parkinson's disease	0.000147	0.00145	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NQO1—Parkinson's disease	0.000146	0.00144	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TH—Parkinson's disease	0.000143	0.00141	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000143	0.00141	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—MTHFR—Parkinson's disease	0.000142	0.0014	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000142	0.0014	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00014	0.00138	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYCS—Parkinson's disease	0.000138	0.00136	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000136	0.00134	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—APOE—Parkinson's disease	0.000132	0.00131	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—COMT—Parkinson's disease	0.000122	0.0012	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTP1—Parkinson's disease	0.000121	0.0012	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MAOA—Parkinson's disease	0.000121	0.00119	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—HMOX1—Parkinson's disease	0.00012	0.00118	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000117	0.00116	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000117	0.00115	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000116	0.00115	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000116	0.00114	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000115	0.00114	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ABCB1—Parkinson's disease	0.000115	0.00113	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—INS—Parkinson's disease	0.000113	0.00112	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTM1—Parkinson's disease	0.000112	0.0011	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ND3—Parkinson's disease	0.000109	0.00108	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MCCC1—Parkinson's disease	0.000109	0.00108	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000107	0.00106	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GPX1—Parkinson's disease	0.000107	0.00105	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000106	0.00104	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TALDO1—Parkinson's disease	0.000103	0.00101	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—OMD—Parkinson's disease	0.000103	0.00101	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000101	0.000998	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.98e-05	0.000984	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—MTHFR—Parkinson's disease	9.86e-05	0.000972	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	9.76e-05	0.000962	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GCH1—Parkinson's disease	9.31e-05	0.000918	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.26e-05	0.000913	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—APOE—Parkinson's disease	9.18e-05	0.000905	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.13e-05	0.0009	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GBA—Parkinson's disease	8.3e-05	0.000818	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—FBP1—Parkinson's disease	8.3e-05	0.000818	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—DBH—Parkinson's disease	8.3e-05	0.000818	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—INS—Parkinson's disease	7.84e-05	0.000773	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.67e-05	0.000756	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.63e-05	0.000753	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.62e-05	0.000751	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ND3—Parkinson's disease	7.61e-05	0.00075	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MCCC1—Parkinson's disease	7.61e-05	0.00075	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.56e-05	0.000746	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.53e-05	0.000742	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.15e-05	0.000705	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—OMD—Parkinson's disease	7.15e-05	0.000705	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.02e-05	0.000692	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.92e-05	0.000682	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.78e-05	0.000669	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.47e-05	0.000638	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—DDC—Parkinson's disease	6.09e-05	0.0006	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GBA—Parkinson's disease	5.77e-05	0.000569	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—DBH—Parkinson's disease	5.77e-05	0.000569	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.77e-05	0.000569	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTA4—Parkinson's disease	5.75e-05	0.000567	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	5.18e-05	0.00051	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MAOB—Parkinson's disease	5.12e-05	0.000505	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ND3—Parkinson's disease	4.97e-05	0.00049	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.97e-05	0.00049	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—OMD—Parkinson's disease	4.68e-05	0.000461	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.68e-05	0.000461	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.43e-05	0.000437	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—DDC—Parkinson's disease	4.23e-05	0.000417	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.23e-05	0.000417	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4e-05	0.000394	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	3.81e-05	0.000376	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.77e-05	0.000372	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—DBH—Parkinson's disease	3.77e-05	0.000372	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GBA—Parkinson's disease	3.77e-05	0.000372	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CTGF—Parkinson's disease	3.74e-05	0.000369	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.6e-05	0.000355	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.56e-05	0.000351	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	3.48e-05	0.000344	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NQO1—Parkinson's disease	3.44e-05	0.00034	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TH—Parkinson's disease	3.39e-05	0.000335	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYCS—Parkinson's disease	3.26e-05	0.000321	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—COMT—Parkinson's disease	2.89e-05	0.000285	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—Parkinson's disease	2.87e-05	0.000283	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MAOA—Parkinson's disease	2.87e-05	0.000283	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HMOX1—Parkinson's disease	2.83e-05	0.000279	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—DDC—Parkinson's disease	2.77e-05	0.000273	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCB1—Parkinson's disease	2.72e-05	0.000268	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTM1—Parkinson's disease	2.64e-05	0.00026	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.61e-05	0.000258	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.6e-05	0.000256	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GPX1—Parkinson's disease	2.53e-05	0.000249	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.42e-05	0.000239	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.39e-05	0.000236	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TH—Parkinson's disease	2.36e-05	0.000233	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.35e-05	0.000232	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTHFR—Parkinson's disease	2.33e-05	0.00023	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.33e-05	0.00023	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.27e-05	0.000223	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—APOE—Parkinson's disease	2.17e-05	0.000214	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—COMT—Parkinson's disease	2.01e-05	0.000198	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2e-05	0.000197	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.99e-05	0.000196	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.97e-05	0.000194	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.89e-05	0.000186	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—INS—Parkinson's disease	1.86e-05	0.000183	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.83e-05	0.000181	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.76e-05	0.000173	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.73e-05	0.000171	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.7e-05	0.000168	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.62e-05	0.00016	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.58e-05	0.000156	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.57e-05	0.000154	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TH—Parkinson's disease	1.54e-05	0.000152	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—APOE—Parkinson's disease	1.51e-05	0.000149	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.48e-05	0.000146	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—COMT—Parkinson's disease	1.31e-05	0.000129	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.31e-05	0.000129	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.3e-05	0.000128	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—INS—Parkinson's disease	1.29e-05	0.000127	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.29e-05	0.000127	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.24e-05	0.000122	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.2e-05	0.000118	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.15e-05	0.000113	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.06e-05	0.000105	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—APOE—Parkinson's disease	9.87e-06	9.73e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—INS—Parkinson's disease	8.43e-06	8.32e-05	CbGpPWpGaD
